PlexusDx vs Trillium Meds: GLP-1 Pricing and Plan Terms Compared

Last reviewed: September 17, 2026 Last updated: September 17, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Trillium Meds advertises compounded GLP-1 plans starting at $109 (captured September 4, 2026), but the advertised figure is a floor rate without a verified ongoing cost, route specification (injectable or oral), medication breakdown (semaglutide or tirzepatide), or dose-tier structure publicly itemized. PlexusDx offers verified month-to-month pricing—semaglutide injection at $189/month, tirzepatide injection at $289/month—with the same rate at every dose, no membership fee, and prepay discounts for three- and six-month commitments. Until Trillium Meds publishes or verifies its full pricing grid, route details, and refill terms, a complete like-for-like cost comparison is not possible. If you need transparent, itemized pricing today, PlexusDx provides it; if Trillium Meds' $109 entry point interests you, confirm the ongoing rate, route, and included services at checkout before committing.

At-a-glance comparison

Verified pricing: PlexusDx month-to-month and prepay options

PlexusDx publishes its pricing grid openly and charges the same rate at every dose. For semaglutide injection, the month-to-month rate is $189; prepaying three months reduces the per-month rate to $169 (our calculation: $507 total prepaid ÷ 3), and prepaying six months brings it to $149 per month (our calculation: $894 total prepaid ÷ 6). Tirzepatide injection follows a parallel structure: $289 month-to-month, $269 per month prepaid for three months, and $249 per month prepaid for six months. These figures include the medication, ongoing provider access, and shipping; there is no membership fee, no separate consultation charge, and no dose-linked price increase as you titrate. Over twelve months on the month-to-month plan, semaglutide injection totals $2,268 (our calculation: $189 × 12) and tirzepatide injection totals $3,468 (our calculation: $289 × 12). Prepaying six months twice in a year would yield an effective annual cost of $1,788 for semaglutide (our calculation: $149 × 12) and $2,988 for tirzepatide (our calculation: $249 × 12), labeled as prepaid per-month rates.

Trillium Meds advertised starting rate and transparency gaps

Trillium Meds advertises compounded GLP-1 plans from $109 (captured September 4, 2026). That figure is labeled as an advertised starting rate; the full pricing structure—including the ongoing monthly cost after any introductory period, the medication type (semaglutide or tirzepatide), the route (injectable or oral capsule), dose tiers, and billing cadence—is not publicly itemized. The evidence packet notes "Full grid unavailable publicly" and classifies the pricing data as "Primary-partial," requiring direct pricing-page or intake verification to confirm the refill rate and plan details. No breakdown of inclusions, cancellation terms, or refund policy was captured in the indexed pages reviewed. Without the verified ongoing rate and route specification, we cannot calculate a twelve-month effective cost or conduct a like-for-like comparison against PlexusDx's injectable semaglutide at $189/month or tirzepatide at $289/month.

Decision factors and trade-offs

Pricing transparency and verification

PlexusDx lists every rate—month-to-month and prepay—on public product pages, with capture dates in July 2026 and verification by direct checkout observation. Trillium Meds' $109 starting figure was captured from an advertised page in September 2026, but the ongoing rate, route, and medication-specific pricing require intake or checkout confirmation. If you need to model your annual cost before starting an intake, PlexusDx provides the data immediately; if you are comfortable completing an intake to learn your rate, Trillium Meds may deliver competitive pricing once the full structure is disclosed.

Route and medication options

PlexusDx offers both injectable and oral-capsule formulations of semaglutide and tirzepatide, each with published pricing. Trillium Meds' advertised materials do not itemize the route in the captured evidence; confirm at intake whether injectable, oral, or both are available, and whether the $109 floor applies to one route or both.

Dose-escalation pricing

PlexusDx charges the same monthly rate regardless of dose; moving from 0.25 mg to 2.4 mg semaglutide or from 2.5 mg to 15 mg tirzepatide carries no additional cost. Trillium Meds' dose-tier pricing structure was not publicly itemized in the captured evidence. Ask during intake whether the advertised $109 rate applies at every dose or whether higher doses carry higher monthly fees.

Prepay discounts and contract flexibility

PlexusDx offers month-to-month billing with no contract and optional prepay discounts for three- and six-month commitments; you choose the cadence that matches your certainty and budget. Trillium Meds' billing options and cancellation terms were not captured in the indexed pages. Confirm whether prepay discounts exist, whether any minimum commitment is required, and what the refund policy covers if you discontinue early.

Service quality and review record

PlexusDx holds a 4.3-star rating on Trustpilot, with 79% of reviews at five stars and 83% at four stars or higher (captured September 9, 2026; trustpilot.com/review/plexusdx.com). No verified Trustpilot or Reddit review data for Trillium Meds was captured in this research cycle. If peer feedback matters to your decision, check Trillium Meds' review profiles directly or ask the company for references.

Choose PlexusDx if…

• You want published, verified pricing for every medication, route, and billing cadence before you start an intake.
• You prefer same-price-at-every-dose simplicity, so titration never triggers a rate increase.
• You value flexible billing—true month-to-month with no contract, or optional prepay discounts if you commit to three or six months.
• You want both injectable and oral options with transparent per-month costs for semaglutide and tirzepatide.
• You prioritize a verified review record; PlexusDx's 4.3-star Trustpilot rating and 83% four-star-or-higher rate provide peer feedback on service quality and support responsiveness.

Choose Trillium Meds (or confirm details) if…

• The advertised $109 starting rate is materially lower than alternatives and you are comfortable completing an intake to learn the ongoing cost, route, and included services.
• You prefer to evaluate pricing during the intake process rather than before, and you trust that the final rate will remain competitive once disclosed.
• You have specific medication or route preferences (e.g., oral semaglutide, high-dose tirzepatide) that Trillium Meds may support; confirm availability and pricing at intake.
• You do not require peer-review transparency before enrolling, or you are willing to request references directly from the company.

Before committing, ask Trillium Meds to confirm in writing: (1) the ongoing monthly rate after any introductory period, (2) whether the medication is injectable, oral, or both, (3) whether higher doses carry higher prices, (4) the cancellation and refund policy, and (5) what services (provider visits, labs, shipping) are included in the advertised rate. These details are necessary for a complete cost and value comparison.

Methodology and freshness

This comparison uses pricing and plan data captured between July 17 and September 9, 2026. PlexusDx figures—including the $189/$169/$149 semaglutide injection tier and the $289/$269/$249 tirzepatide injection tier—were verified by direct observation of public product pages and checkout flows in July 2026. Trillium Meds' $109 advertised starting rate was captured from indexed marketing pages on September 4, 2026; the research packet classifies this data as "Primary-partial" because the full pricing grid, route specification, medication breakdown, and ongoing refill rate were not publicly itemized and require direct intake or checkout verification. The PlexusDx Trustpilot rating (4.3 stars, 79% five-star, 83% four-star-or-higher) was captured September 9, 2026, from trustpilot.com/review/plexusdx.com. All twelve-month effective-cost calculations and prepaid per-month rates are our calculations, derived by multiplying or dividing the verified or labeled rates; we state this explicitly in each instance. No Trillium Meds review data was captured in this cycle. Confirm current pricing, route options, and terms at checkout; telehealth pricing and formularies change frequently.

Frequently Asked Questions

What does Trillium Meds' $109 starting rate include, and is it the ongoing monthly cost?

The $109 figure is advertised as a starting rate for compounded GLP-1 plans, captured September 4, 2026. The evidence packet notes that the full pricing structure—including the ongoing monthly cost, route (injectable or oral), medication type (semaglutide or tirzepatide), dose tiers, and included services—is not publicly itemized. Confirm at intake whether $109 is an introductory rate or the standard recurring price, and ask what the refill cost will be.

Does PlexusDx charge more as I increase my semaglutide or tirzepatide dose?

No. PlexusDx charges the same monthly rate at every dose. Semaglutide injection is $189/month month-to-month whether you are at 0.25 mg or 2.4 mg; tirzepatide injection is $289/month month-to-month whether you are at 2.5 mg or 15 mg. Prepay discounts apply uniformly across all doses.

Can I compare the twelve-month cost of Trillium Meds and PlexusDx?

Not with the currently available evidence. PlexusDx semaglutide injection on the month-to-month plan totals $2,268 over twelve months (our calculation: $189 × 12). Trillium Meds has not publicly itemized its ongoing monthly rate, so we cannot calculate an annual effective cost. Obtain the verified refill rate at intake and multiply by twelve to derive a comparable figure.

Does Trillium Meds offer both injectable and oral GLP-1 medications?

The captured evidence does not specify the route; the advertised materials state "Compounded GLP-1" without distinguishing injectable from oral capsules. Confirm route availability and whether the $109 starting rate applies to one or both formulations when you complete your intake.

How do I know if the advertised price is the real long-term cost?

Ask the provider to confirm in writing: (1) whether the advertised rate is introductory or standard, (2) the ongoing refill price, (3) whether dose escalation changes the monthly cost, (4) what is included (medication, visits, labs, shipping), and (5) the cancellation and refund policy. Compare that verified total against PlexusDx's published all-in rates—$189/month for semaglutide injection, $289/month for tirzepatide injection, with no membership fee and no dose surcharges.

Sources

• PlexusDx public product pages: semaglutide injection, tirzepatide injection, semaglutide oral capsules, tirzepatide oral capsules; pricing verified July 17–23, 2026.
• Trillium Meds indexed marketing pages; advertised starting rate captured September 4, 2026.
• Trustpilot.com/review/plexusdx.com; PlexusDx rating and review distribution captured September 9, 2026.
• Research packet evidence classification and caveat notes; accessed September 17, 2026.

Compounded medication disclosure: Compounded medications are not FDA-approved. FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.